All News #Library
Rare Diseases
Y-mAbs` rare disease drug roundly rejected by FDA AdComm over weakness
01 Nov 2022 //
FIERCEBIOTECH
Y-mAbs’ 177Lu-omburtamab-DTPA Receives Positive Opinion on Orphan Designation
25 Jun 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support